← Leaderboards
Richard J Barth
Dartmouth College
$711,764
Attributed
$711,764
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$711,764 · 2
By mechanism
P20$377,864 · 1
R29$333,900 · 1
Top collaborators
No co-investigators on record.
Most similar at Dartmouth College
Same institution · by research overlap
- Lloyd H Kasper$9,400,939
- William R Green$40,677,734
- Marc S Ernstoff$5,989,395
- Li Lily Wang$7,371,035
- Joyce A Deleo$6,015,876
Others in their field
Top investigators on “Cd40 Molecule”
- Jacques F Banchereau · Rockefeller University$17,936,253
- Rama Rao Amara · Emory University$11,504,642
- Yong-Jun Liu · University Of Texas Md Anderson Can Ctr$11,265,744
- Jerzy W. Kupiec-Weglinski · University Of California Los Angeles$9,822,350
- Lewis C Becker · Johns Hopkins University$8,751,227
- Randolph J. Noelle · University Of Minnesota$8,492,235
Research focus
Cd40 MoleculeNeoplasm /Cancer VaccineColorectal NeoplasmsCombination Cancer TherapyLongitudinal Human StudyMetastasisCytokineNeoplasm /Cancer ImmunologyNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer SurgeryNonhuman Therapy EvaluationPatient Oriented ResearchDendritic CellsScintillation CounterCell Population StudyEnzyme Linked Immunosorbent AssayFlow CytometryChemical Structure FunctionT LymphocyteHuman SubjectHuman Therapy EvaluationClinical TrialsImmunologic Substance Development /PreparationImmunomodulators
Grant awards (8)
COBRE: CD40 ACTIVATED DENDRITIC CELL VACCINE IN PATIENTS W/ COLORECTAL CANCER$112,996
P20 · FY2005 · RR
CD40 ACTIVATED DENDRITIC CELL VACCINE IN PATIENTS W/ COLORECTAL CANCER$264,868
P20 · FY2004 · RR
MECHANISMS UNDERLYING CD40LS ROLE IN TUMOR IMMUNITY$111,300
R29 · FY2002 · CA
COLORECTAL CANCER: CD40 CELL VACCINE THERAPY$0
P20 · FY2002 · RR
COLORECTAL CANCER: CD40 CELL VACCINE THERAPY$0
P20 · FY2002 · RR
MECHANISMS UNDERLYING CD40LS ROLE IN TUMOR IMMUNITY$111,300
R29 · FY2001 · CA
COLORECTAL CANCER: CD40 CELL VACCINE THERAPY$0
P20 · FY2001 · RR
MECHANISMS UNDERLYING CD40LS ROLE IN TUMOR IMMUNITY$111,300
R29 · FY2000 · CA